Eris Lifesciences to buy some dermatology brands from Glenmark Pharma

The deal, through Eris' dermatology focused unit, is for the purchase of nine brands, including Onabet, Halobate, Sorvate, and Demelan for India and Nepal, Eris said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/LArowck
via IFTTT